What is the recommended tapering schedule to discontinue bupropion HCl 75 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bupropion HCl 75 mg Does Not Require Tapering for Discontinuation

For patients on bupropion HCl 75 mg once daily, you can discontinue the medication abruptly without tapering. This low dose is well below the threshold where gradual dose reduction is recommended.

Why No Taper is Needed at 75 mg

The FDA-approved prescribing information for bupropion HCl extended-release specifically addresses tapering only for patients on 300 mg daily doses 1. The guidance states: "When discontinuing treatment in patients treated with bupropion hydrochloride extended-release tablets (XL) 300 mg once daily, decrease the dose to 150 mg once daily prior to discontinuation" 1.

Since your patient is already at 75 mg—half the dose at which tapering begins—no further dose reduction is necessary before stopping.

Key Clinical Considerations

Bupropion's Unique Pharmacology

  • Bupropion is a dopamine/norepinephrine reuptake inhibitor, not a serotonin reuptake inhibitor 2
  • It has a biphasic elimination with a redistribution half-life of approximately 1.5 hours and an elimination half-life of 14 hours 3
  • Unlike SSRIs/SNRIs, bupropion does not typically cause significant withdrawal syndromes when discontinued

When Tapering IS Recommended

The only scenario where bupropion tapering is explicitly recommended is:

  • Patients on 300 mg daily: Reduce to 150 mg once daily, then discontinue 1
  • This applies to both Major Depressive Disorder and Seasonal Affective Disorder indications

Monitoring After Discontinuation

While abrupt discontinuation at 75 mg is safe, monitor for:

  • Neuropsychiatric symptoms: Although uncommon, watch for emergence of depression, anxiety, or mood changes 4
  • Return of underlying symptoms: If treating depression, ensure appropriate follow-up for potential relapse
  • Seizure risk normalization: Bupropion lowers seizure threshold; this risk resolves after discontinuation 4

Common Pitfall to Avoid

Do not apply SSRI/SNRI tapering principles to bupropion. Recent evidence emphasizes the importance of hyperbolic, gradual tapers for serotonergic antidepressants to avoid withdrawal symptoms 5, 6, 7. However, bupropion's distinct mechanism (dopamine/norepinephrine vs. serotonin) means it does not carry the same withdrawal risk profile. The alternate-day dosing strategy sometimes used for SSRIs would be inappropriate and unnecessary for bupropion at this dose 5.

Practical Implementation

For a patient on bupropion HCl 75 mg once daily:

  1. Simply stop the medication after the last dose
  2. Schedule follow-up within 2-4 weeks to assess for symptom recurrence
  3. Counsel the patient that they may notice return of original symptoms (if treating depression/SAD) but should not expect withdrawal effects
  4. Document the indication for which bupropion was prescribed to guide monitoring

The evidence is clear: at 75 mg daily, no tapering schedule is needed—just discontinue.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.